BlackRock
HCAT icon

BlackRock’s Health Catalyst HCAT Stock Holding History

BlackRock’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.65M Sell
1,836,373
-3,301,649
-64% -$4.77M ﹤0.01% 4010
2026
Q1 		$6.53M Sell
5,138,022
-55,063
-1% -$104K ﹤0.01% 3724
2025
Q4 		$12.4M Sell
5,193,085
-310,318
-6% -$849K ﹤0.01% 3366
2025
Q3 		$15.7M Sell
5,503,403
-148,170
-3% -$507K ﹤0.01% 3237
2025
Q2 		$21.3M Sell
5,651,573
-110,422
-2% -$434K ﹤0.01% 2983
2025
Q1 		$26.1M Buy
5,761,995
+178,119
+3% +$943K ﹤0.01% 2781
2024
Q4 		$39.5M Buy
5,583,876
+45,767
+0.8% +$364K ﹤0.01% 2608
2024
Q3 		$45.1M Buy
5,538,109
+105,400
+2% +$762K ﹤0.01% 2530
2024
Q2 		$34.7M Buy
5,432,709
+68,224
+1% +$438K ﹤0.01% 2640
2024
Q1 		$40.4M Buy
5,364,485
+45,914
+0.9% +$419K ﹤0.01% 2569
2023
Q4 		$49.2M Buy
5,318,571
+375,966
+8% +$3.07M ﹤0.01% 2482
2023
Q3 		$50M Buy
4,942,605
+183,332
+4% +$2.19M ﹤0.01% 2393
2023
Q2 		$59.5M Buy
4,759,273
+8,631
+0.2% +$103K ﹤0.01% 2383
2023
Q1 		$55.4M Sell
4,750,642
-81,706
-2% -$1.04M ﹤0.01% 2373
2022
Q4 		$51.4M Buy
4,832,348
+213,877
+5% +$2.06M ﹤0.01% 2443
2022
Q3 		$44.8M Sell
4,618,471
-119,194
-3% -$1.58M ﹤0.01% 2523
2022
Q2 		$68.6M Buy
4,737,665
+98,476
+2% +$1.68M ﹤0.01% 2272
2022
Q1 		$121M Sell
4,639,189
-60,203
-1% -$1.71M ﹤0.01% 2014
2021
Q4 		$186M Buy
4,699,392
+23,211
+0.5% +$1.06M ﹤0.01% 1785
2021
Q3 		$234M Buy
4,676,181
+156,525
+3% +$8.54M 0.01% 1591
2021
Q2 		$251M Buy
4,519,656
+1,991,894
+79% +$106M 0.01% 1602
2021
Q1 		$118M Sell
2,527,762
-3,638
-0.1% -$176K ﹤0.01% 2095
2020
Q4 		$110M Buy
2,531,400
+308,836
+14% +$11.4M ﹤0.01% 2030
2020
Q3 		$81.3M Buy
2,222,564
+380,217
+21% +$12.9M ﹤0.01% 2014
2020
Q2 		$53.7M Buy
1,842,347
+760,574
+70% +$21M ﹤0.01% 2213
2020
Q1 		$28.3M Buy
1,081,773
+472,962
+78% +$14.5M ﹤0.01% 2417
2019
Q4 		$21.1M Sell
608,811
-25,146
-4% -$832K ﹤0.01% 2848
2019
Q3 		$20.1M Buy
+633,957
New +$25M ﹤0.01% 2822

Other funds holding HCAT

FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
CF
CDC Financial Chicago, Illinois $239M AUM
PVM
Palogic Value Management Dallas, Texas $304M AUM 15.15% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return
NI
Nepsis Inc Minneapolis, Minnesota $295M AUM 35.44% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HWM
HighMark Wealth Management St. Paul, Minnesota $299M AUM 53.01% 1-Year Est. Return

BlackRock's HCAT Position: Q2 2026 in Review

BlackRock reduced its Health Catalyst (HCAT) stake by 64% in Q2 2026, selling an estimated $4.77M and leaving 1,836,373 shares worth $3.65M. The position accounts for ﹤0.01% of the portfolio, ranked #4010.

BlackRock first reported a position in HCAT in Q3 2019 and has held it in 28 quarters since. The position peaked at $251M in Q2 2021. 127 funds tracked by Wall St. Rank hold HCAT as of Q2 2026.

  • BlackRock held 1,836,373 shares of Health Catalyst worth $3.65M as of Q2 2026.
  • BlackRock sold 3,301,649 Health Catalyst shares in Q2 2026, an estimated $4.77M.
  • Health Catalyst made up ﹤0.01% of BlackRock's portfolio in Q2 2026, its #4010 holding.
  • BlackRock first reported a position in Health Catalyst in Q3 2019 and has held it in 28 quarters since.
  • BlackRock's Health Catalyst position peaked at $251M in Q2 2021.
  • 127 funds tracked by Wall St. Rank held Health Catalyst as of Q2 2026.

Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.